Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 454680, 3 pages
http://dx.doi.org/10.1155/2015/454680
Editorial

Bridging the Gap between Translational and Outcome Research in Cardiovascular Disease

1Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy
2Department of AngioCardioNeurology, IRCCS Neuromed, Via Atinense 18, 86077 Pozzilli, Italy
3Oxford Heart Center, Oxford University Hospital, Headley Way, Oxford OX3 9DU, UK
4Eleonora Lorillard Spencer Cenci Foundation, Rome, Italy
5Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103, USA

Received 7 October 2015; Accepted 11 October 2015

Copyright © 2015 Giacomo Frati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics-2015 update: a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. e29–e39, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Vasan, “Biomarkers of cardiovascular disease: molecular basis and practical considerations,” Circulation, vol. 113, no. 19, pp. 2335–2362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Yeboah, A. R. Folsom, G. L. Burke et al., “Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis,” Circulation, vol. 120, no. 6, pp. 502–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. E. Humphries, F. Drenos, G. Ken-Dror, and P. J. Talmud, “Coronary heart disease risk prediction in the era of genome-wide association studies: current status and what the future holds,” Circulation, vol. 121, no. 20, pp. 2235–2248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Barbato, J. Bartunek, F. Mangiacapra et al., “Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease,” Journal of the American College of Cardiology, vol. 59, no. 20, pp. 1763–1770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Schwartz Longacre, R. A. Kloner, A. E. Arai et al., “New horizons in cardioprotection: recommendations from the 2010 national heart, lung, and blood institute workshop,” Circulation, vol. 124, no. 10, pp. 1172–1179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Biondi-Zoccai, E. De Falco, M. Peruzzi et al., “A novel closed-chest porcine model of chronic ischemic heart failure suitable for experimental research in cardiovascular disease,” BioMed Research International, vol. 2013, Article ID 410631, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Gaetani, G. Rizzitelli, I. Chimenti et al., “Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application,” Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1071–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. N. Nowbar, M. Mielewczik, M. Karavassilis et al., “Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis,” British Medical Journal, vol. 348, Article ID g2688, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Peruzzi, E. De Falco, A. Abbate et al., “State of the art on the evidence base in cardiac regenerative therapy: overview of 41 systematic reviews,” BioMed Research International, vol. 2015, Article ID 613782, 7 pages, 2015. View at Publisher · View at Google Scholar
  11. C. Fabrizi, F. Angelini, I. Chimenti et al., “Thrombin and thrombin-derived peptides promote proliferation of cardiac progenitor cells in the form of cardiospheres without affecting their differentiation potential,” Journal of Biological Regulators and Homeostatic Agents, vol. 25, no. 2, supplement, pp. S43–S51, 2011. View at Google Scholar · View at Scopus
  12. I. Chimenti, R. Gaetani, E. Forte et al., “Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture,” Journal of Cellular and Molecular Medicine, vol. 18, no. 4, pp. 624–634, 2014. View at Publisher · View at Google Scholar · View at Scopus